Uroplasty Reports Financial Results for the Second Quarter FY2011
MINNEAPOLIS, Oct. 27 /PRNewswire-FirstCall/ — Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the second fiscal quarter ended September 30, 2010. Global sales grew 9% driven primarily by a 50% increase in Macroplastique product sales in the U.S. “We …
Read more on redOrbit
Leave a Reply